|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Queensland Institute of Medical Research, Brisbane, Queensland, Australia
2 Queensland Institute of Medical Research, Brisbane, Queensland, Australia; , Australia
* To whom correspondence should be addressed. E-mail: Nathan.Subramaniam{at}qimr.edu.au.
ABSTRACT Transferrin receptor 2 (TfR2), a homologue of transferrin receptor 1 (TfR1), is a key molecule involved in the regulation of iron homeostasis. Mutations in TfR2 result in iron overload with similar features to HFE-associated hereditary hemochromatosis. The precise role of TfR2 in iron metabolism and the functional consequences of disease causing mutations have not been fully determined. We have expressed wild-type and various mutant forms of TfR2 that are associated with human disease in a mouse liver cell line. Intracellular and surface analysis shows that all the transferrin receptor 2 mutations analyzed cause the intracellular retention of the protein in the endoplasmic reticulum, while the wild-type protein is expressed in endocytic structures and at the cell surface. Our results indicate that the majority of mutations which cause type 3 hereditary hemochromatosis are a consequence of the defective localization of the protein.
This article has been cited by other articles:
![]() |
S. Pelucchi, R. Mariani, P. Trombini, S. Coletti, M. Pozzi, V. Paolini, D. Barisani, and A. Piperno Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2 Haematologica, February 1, 2009; 94(2): 276 - 279. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |